Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype
Authors:
Open Access
- 1 April 2016
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 96 (4) , 391-398
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Combination Erlotinib-Cisplatin and Atg3-Mediated Autophagy in Erlotinib Resistant Lung CancerPLOS ONE, 2012
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- The dynamic nature of autophagy in cancerGenes & Development, 2011
- A Distinct Role for Pin1 in the Induction and Maintenance of PluripotencyJournal of Biological Chemistry, 2011
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- The Prolyl Isomerase Pin1 Induces LC-3 Expression and Mediates Tamoxifen Resistance in Breast CancerJournal of Biological Chemistry, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Novel mutant-selective EGFR kinase inhibitors against EGFR T790MNature, 2009
- Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylationOncogene, 2009
- Down-regulation of Myeloid Cell Leukemia-1 through Inhibiting Erk/Pin 1 Pathway by Sorafenib Facilitates Chemosensitization in Breast CancerCancer Research, 2008